Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Change in Cash: 2019-2025

Historic Change in Cash for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to $11.7 million.

  • Eton Pharmaceuticals' Change in Cash rose 357.42% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year increase of 1032.01%. This contributed to the annual value of -$6.5 million for FY2024, which is 226.93% down from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Change in Cash of $11.7 million as of Q3 2025, which was up 47.53% from $8.0 million recorded in Q2 2025.
  • Eton Pharmaceuticals' Change in Cash's 5-year high stood at $11.7 million during Q3 2025, with a 5-year trough of -$8.3 million in Q4 2021.
  • Moreover, its 3-year median value for Change in Cash was $1.0 million (2024), whereas its average is $1.9 million.
  • In the last 5 years, Eton Pharmaceuticals' Change in Cash spiked by 1,319.33% in 2021 and then plummeted by 680.79% in 2024.
  • Over the past 5 years, Eton Pharmaceuticals' Change in Cash (Quarterly) stood at -$8.3 million in 2021, then soared by 135.25% to $2.9 million in 2022, then tumbled by 123.30% to -$682,000 in 2023, then tumbled by 680.79% to -$5.3 million in 2024, then spiked by 357.42% to $11.7 million in 2025.
  • Its Change in Cash was $11.7 million in Q3 2025, compared to $8.0 million in Q2 2025 and $2.5 million in Q1 2025.